Market Cap
₹2,023 Cr.
P/E
0.00
About
Camlin Fine Sciences Limited is a leading integrated manufacturer of traditional antioxidants and other chemical solutions. They specialize in shelf life solutions, aroma ingredients, health & wellnes… Read more
Camlin Fine Sciences Limited is a leading integrated manufacturer of traditional antioxidants … Read more
Low
80
52W Range
High
186
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Forensics

7 Yes

Positive for this company

2 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
-10.73%
3yr Average
1.25%
5yr Average
3.84%
Net Profit Margin
Latest
-5.75%
3yr Average
0.55%
5yr Average
1.77%
ROCE
Latest
1.74%
3yr Average
8.64%
5yr Average
11.62%
Debt to Equity
Latest
0.76
3yr Average
0.85
5yr Average
0.94
Revenue mix

Product Wise Break-Up

Product Wise Break-Up - Performance Chemicals

Product Wise Break-Up - Shelf-Life

Location Wise Break-Up

Operational Metrics

    Select a Metric
    • Manufacturing Capacity - Speciality Chemicals (MTPA)
    Peer Comparison
    Suppliers
    • Hindusthan National Glass & Industries Ltd.
    Customers
    • Adani Wilmar Ltd.
    • Cargill
    • Clariant
    • Dow Chemical Company
    • Evonik Industries
    FAQs on Camlin Fine Sciences Ltd. Business

    Camlin Fine Sciences is a reputable manufacturer specializing in traditional antioxidants, aroma ingredients, and performance chemicals, prioritizing quality and customer service to establish a strong presence in the industry.

    Camlin Fine Sciences major competitors are Privi Speciality Che, Clean Science, Sadhana Nitro Chem, Tanfac Industries, Paushak, Tatva Chintan Pharma, Ultramar & Pigments.
    Market Cap of Camlin Fine Sciences is ₹2,023 Crs.
    While the median market cap of its peers are ₹2,070 Crs.

    Camlin Fine Sciences seems to be less financially stable compared to its peers.
    Altman Z score of Camlin Fine Sciences is 2.66 and is ranked 8 out of its 8 competitors.

    Company Filing
    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary Jun Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Discussions & Analysis